BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Woude CJ, Jansen PL, Tiebosch AT, Beuving A, Homan M, Kleibeuker JH, Moshage H. Expression of apoptosis-related proteins in Barrett’s metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype. Hum Pathol. 2002;33:686-692. [PMID: 12196918 DOI: 10.1053/hupa.2002.124908] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ju X, Yu H, Liang D, Jiang T, Liu Y, Chen L, Dong Q, Liu X. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions. Biomed Pharmacother 2018;102:549-54. [PMID: 29597088 DOI: 10.1016/j.biopha.2018.03.092] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
2 Naini BV, Souza RF, Odze RD. Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol. 2016;40:e45-e66. [PMID: 26813745 DOI: 10.1097/pas.0000000000000598] [Cited by in Crossref: 77] [Cited by in F6Publishing: 109] [Article Influence: 11.0] [Reference Citation Analysis]
3 Spechler SJ, Wang DH, Souza RF. Barrett Esophagus and Esophageal Adenocarcinoma. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch52] [Reference Citation Analysis]
4 Zhong D, Gu C, Shi L, Xun T, Li X, Liu S, Yu L. Obatoclax induces G1/G0-phase arrest via p38/p21(waf1/Cip1) signaling pathway in human esophageal cancer cells. J Cell Biochem 2014;115:1624-35. [PMID: 24788582 DOI: 10.1002/jcb.24829] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
5 Zhou HB, Chen JM, Shao LM, Chen ZG. Apoptosis of human pancreatic carcinoma cell-1 cells induced by Yin Chen Hao Decoction. World J Gastroenterol 2015; 21(27): 8352-8357 [PMID: 26217086 DOI: 10.3748/wjg.v21.i27.8352] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
6 Scarpa M, Castagliuolo I, Castoro C, Pozza A, Scarpa M, Kotsafti A, Angriman I. Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World J Gastroenterol 2014; 20(22): 6774-6785 [PMID: 24944468 DOI: 10.3748/wjg.v20.i22.6774] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
7 Yu L, Liu S. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics. Semin Cancer Biol 2013;23:553-60. [PMID: 24012660 DOI: 10.1016/j.semcancer.2013.08.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
8 Clemons NJ, Phillips WA, Lord RV. Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction. Cancer Biol Ther. 2013;14:782-795. [PMID: 23792587 DOI: 10.4161/cbt.25362] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
9 Li Y, Han F, Shi Y. Increased neuronal apoptosis in medial prefrontal cortex is accompanied with changes of Bcl-2 and Bax in a rat model of post-traumatic stress disorder. J Mol Neurosci 2013;51:127-37. [PMID: 23381833 DOI: 10.1007/s12031-013-9965-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
10 Younes M. Molecular Pathology of Barrett’s Metaplasia and Esophageal Adenocarcinoma. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Rawat N, Alhamdani A, McAdam E, Cronin J, Eltahir Z, Lewis P, Griffiths P, Baxter JN, Jenkins GJ. Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett’s oesophagus. Clin Transl Oncol. 2012;14:302-311. [PMID: 22484638 DOI: 10.1007/s12094-012-0799-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
12 Baptissart M, Vega A, Maqdasy S, Caira F, Baron S, Lobaccaro JM, Volle DH. Bile acids: from digestion to cancers. Biochimie. 2013;95:504-517. [PMID: 22766017 DOI: 10.1016/j.biochi.2012.06.022] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 7.2] [Reference Citation Analysis]
13 Thrumurthy SG, Lewis CJ, Pritchard S, Armstrong G, Attwood SEA. Reply to Letter to the Editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First). Surg Endosc 2012;26:291-292. [DOI: 10.1007/s00464-011-1842-7] [Reference Citation Analysis]
14 Kotzev AI, Kamenova MA, Tcherveniakov AP. Immunohistochemical Expression of Ki-67, PCNA, pRb, p16, p53, Bcl-2 and Bax in Esophageal Adenocarcinoma and Barrett’s Associated Dysplasia. JCT 2012;03:1092-1110. [DOI: 10.4236/jct.2012.36143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Wiseman EF, Ang YS. Risk factors for neoplastic progression in Barrett’s esophagus. World J Gastroenterol 2011; 17(32): 3672-3683 [PMID: 21990948 DOI: 10.3748/wjg.v17.i32.3672] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
16 Masini E, Cianchi F, Mastroianni R, Cuzzocrea S. Nitric Oxide Expression in Cancer. Nitric Oxide (NO) and Cancer 2010. [DOI: 10.1007/978-1-4419-1432-3_4] [Reference Citation Analysis]
17 Coppola D, Nasir NA, Turner L. Genesis of Barrett’s Neoplasia: Current Concepts. Mechanisms of Oncogenesis 2010. [DOI: 10.1007/978-90-481-3725-1_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Ding J, Han F, Shi Y. Single-prolonged stress induces apoptosis in the amygdala in a rat model of post-traumatic stress disorder. J Psychiatr Res 2010;44:48-55. [PMID: 19586638 DOI: 10.1016/j.jpsychires.2009.06.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
19 Looby E, Abdel-Latif MM, Athié-Morales V, Duggan S, Long A, Kelleher D. Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells. BMC Cancer. 2009;9:190. [PMID: 19534809 DOI: 10.1186/1471-2407-9-190] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
20 Tischoff I, Tannapfel A. Barrett's esophagus: can biomarkers predict progression to malignancy? Expert Rev Gastroenterol Hepatol 2008;2:653-63. [PMID: 19072343 DOI: 10.1586/17474124.2.5.653] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
21 Li Y, Martin RC. Apoptosis in Carcinogenesis and Chemotherapy – Esophageal Cancer. Apoptosis in Carcinogenesis and Chemotherapy. [DOI: 10.1007/978-1-4020-9597-9_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Hormi-Carver K, Zhang X, Zhang HY, Whitehead RH, Terada LS, Spechler SJ, Souza RF. Unlike Esophageal Squamous Cells, Barrett’s Epithelial Cells Resist Apoptosis by Activating the Nuclear Factor- B Pathway. Cancer Res. 2009;69:672-677. [PMID: 19147583 DOI: 10.1158/0008-5472.can-08-3703] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
23 Hector S, Prehn JH. Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review. Biochim Biophys Acta. 2009;1795:117-129. [PMID: 19167459 DOI: 10.1016/j.bbcan.2008.12.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 53] [Article Influence: 1.5] [Reference Citation Analysis]
24 Selgrad M, Malfertheiner P, Fini L, Goel A, Boland CR, Ricciardiello L. The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol 2008;216:378-88. [PMID: 18338378 DOI: 10.1002/jcp.21427] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
25 Lehr HA, Pusztaszeri M, Bosman FT. Œsophage de Barrett, dysplasie, adénocarcinome: histomorphologie et apport de la biologie moléculaire. Acta Endosc 2008;38:95-105. [DOI: 10.1007/bf02961947] [Reference Citation Analysis]
26 Vaninetti NM, Geldenhuys L, Porter GA, Risch H, Hainaut P, Guernsey DL, Casson AG. Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma. Mol Carcinog. 2008;47:275-285. [PMID: 17849424 DOI: 10.1002/mc.20382] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
27 Zhou HB, Chen JM, Cai JT, Du Q, Wu CN. Anticancer activity of genistein on implanted tumor of human SG7901 cells in nude mice. World J Gastroenterol 2008; 14(4): 627-631 [PMID: 18203299 DOI: 10.3748/wjg.14.627] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
28 Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma. Mol Carcinog 2007;46:971-80. [PMID: 17477358 DOI: 10.1002/mc.20339] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
29 Hennig EE, Mikula M, Orlowska J, Jarosz D, Bielasik A, Regula J, Ostrowski J. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus. J Mol Med (Berl) 2008;86:233-42. [PMID: 17952395 DOI: 10.1007/s00109-007-0271-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
30 Saadi A, Fitzgerald RC. Mechanisms underlying the progression of Barrett's oesophagus. Drug Discovery Today: Disease Mechanisms 2006;3:447-456. [DOI: 10.1016/j.ddmec.2006.10.006] [Reference Citation Analysis]
31 Mehta S, Boddy A, Johnson IT, Rhodes M. Systematic review: Cyclo-oxygenase-2 in human oesophageal adenocarcinogenesis. Aliment Pharmacol Ther 2006;24:1321-31. [PMID: 17059513 DOI: 10.1111/j.1365-2036.2006.03119.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
32 De Gottardi A, Dumonceau JM, Bruttin F, Vonlaufen A, Morard I, Spahr L, Rubbia-Brandt L, Frossard JL, Dinjens WN, Rabinovitch PS, Hadengue A. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer 2006;5:48. [PMID: 17054793 DOI: 10.1186/1476-4598-5-48] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 3.8] [Reference Citation Analysis]
33 Wu C, Lin J, Yang J, Chou S, Chen S, Lin Y, Lin H, Chung J. Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81T/VGH cells through the elevation of intracellular reactive oxygen species and Ca2+ productions and caspase-3 activation. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2006;601:71-82. [DOI: 10.1016/j.mrfmmm.2006.06.015] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 4.1] [Reference Citation Analysis]
34 Vallböhmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, Demeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg P. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma. Surgery 2005;138:701-6; discussion 706-7. [PMID: 16269299 DOI: 10.1016/j.surg.2005.06.051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
35 van der Woude CJ, Moshage H, Homan M, Kleibeuker JH, Jansen PL, van Dekken H. Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. J Clin Pathol. 2005;58:811-814. [PMID: 16049281 DOI: 10.1136/jcp.2004.017418] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wang BC, Guo CQ, Sun C, Sun QL, Liu GY, Li DG. Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer. World J Gastroenterol 2005; 11(21): 3240-3244 [PMID: 15929174 DOI: 10.3748/wjg.v11.i21.3240] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
37 Kyrgidis A, Kountouras J, Zavos C, Chatzopoulos D. New Molecular Concepts of Barrett’s Esophagus: Clinical Implications and Biomarkers. Journal of Surgical Research 2005;125:189-212. [DOI: 10.1016/j.jss.2004.12.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
38 Zhou HB, Yan Y, Cai JT, Du Q, Chen JM. Genistein induces apoptosis in human primary gastric carcinoma cells. Shijie Huaren Xiaohua Zazhi 2005; 13(4): 504-507 [DOI: 10.11569/wcjd.v13.i4.504] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Dvorakova K, Payne CM, Ramsey L, Bernstein H, Holubec H, Chavarria M, Bernstein C, Sampliner RE, Riley C, Prasad A, Garewal H. Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues. Am J Gastroenterol 2005;100:424-31. [PMID: 15667503 DOI: 10.1111/j.1572-0241.2005.40932.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
40 Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005; 11(2): 280-284 [PMID: 15633232 DOI: 10.3748/wjg.v11.i2.280] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 74] [Article Influence: 3.8] [Reference Citation Analysis]
41 Bax DA, Haringsma J, Einerhand AW, van Dekken H, Blok P, Siersema PD, Kuipers EJ, Kusters JG. MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio. J Clin Pathol 2004;57:1267-72. [PMID: 15563666 DOI: 10.1136/jcp.2004.017020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
42 Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN. The molecular biology of esophageal adenocarcinoma. J Surg Oncol 2005;92:169-90. [DOI: 10.1002/jso.20359] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 5.7] [Reference Citation Analysis]
43 Bax DA, Siersema PD, Van Vliet AH, Kuipers EJ, Kusters JG. Molecular alterations during development of esophageal adenocarcinoma. J Surg Oncol 2005;92:89-98. [DOI: 10.1002/jso.20353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
44 Heeren P, Plukker J, van Dullemen H, Nap R, Hollema H. Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma. Cancer Lett 2005;225:283-9. [PMID: 15978332 DOI: 10.1016/j.canlet.2004.11.046] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
45 Nie SN, Sun HC, Wu XH, Qian XM. Cyclooxygenase 2, pS2, inducible nitric oxide synthase and transforming growth factor alpha in gastric adaptation to stress. World J Gastroenterol 2004; 10(23): 3537-3541 [PMID: 15526382 DOI: 10.3748/wjg.v10.i23.3537] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
46 Amano Y, Ishihara S, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D, Miyake T, Miyaoka Y, Rumi MA, Ishimura N, Adachi K, Kinoshita Y. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage. Aliment Pharmacol Ther 2004;20:793-802. [PMID: 15379840 DOI: 10.1111/j.1365-2036.2004.02195.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
47 Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Apoptosis of human primary gastric carcinoma cells induced by genistein. World J Gastroenterol 2004; 10(12): 1822-1825 [PMID: 15188515 DOI: 10.3748/wjg.v10.i12.1822] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
48 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1172-1175 [DOI: 10.11569/wcjd.v12.i5.1172] [Reference Citation Analysis]
49 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1168-1171 [DOI: 10.11569/wcjd.v12.i5.1168] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Caygill CP, Watson A, Lao-Sirieix P, Fitzgerald RC. Barrett’s oesophagus and adenocarcinoma. World J Surg Oncol. 2004;2:12. [PMID: 15132744 DOI: 10.1186/1477-7819-2-12] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
51 Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, Buhtz P, Giers A, Rohrbeck A, Freigang B, Roessner A. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol 2004;164:1233-41. [PMID: 15039212 DOI: 10.1016/S0002-9440(10)63211-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.5] [Reference Citation Analysis]
52 Dvorakova K, Payne CM, Ramsey L, Holubec H, Sampliner R, Dominguez J, Dvorak B, Bernstein H, Bernstein C, Prasad A, Fass R, Cui H, Garewal H. Increased Expression and Secretion of Interleukin-6 in Patients with Barrett’s Esophagus. Clinical Cancer Research 2004;10:2020-2028. [DOI: 10.1158/1078-0432.ccr-0437-03] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 3.5] [Reference Citation Analysis]
53 Schoemaker MH, Gommans WM, Conde de la Rosa L, Homan M, Klok P, Trautwein C, van Goor H, Poelstra K, Haisma HJ, Jansen PL, Moshage H. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 2003;39:153-61. [PMID: 12873810 DOI: 10.1016/s0168-8278(03)00214-9] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 5.1] [Reference Citation Analysis]
54 Sanders D, Taniere P, Harrison R, Jankowski J. Clinical and molecular pathology of the metaplasia–dysplasia–carcinoma sequence in Barrett's oesophagus. Current Diagnostic Pathology 2003;9:235-41. [DOI: 10.1016/s0968-6053(03)00033-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
55 von Rahden BHA, Stein HJ, Siewert JR. Barrett’s esophagus and Barrett’s carcinoma. Curr Oncol Rep 2003;5:203-9. [DOI: 10.1007/s11912-003-0111-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
56 Zhou HB, Yan Y, Sun YN, Zhu JR. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol 2003; 9(3): 408-411 [PMID: 12632486 DOI: 10.3748/wjg.v9.i3.408] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
57 Zhou HB, Zhu JR. Paclitaxel induces apoptosis in human gastric carcinoma cells. World J Gastroenterol 2003; 9(3): 442-445 [PMID: 12632493 DOI: 10.3748/wjg.v9.i3.442] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]